未登录

G

Gary Kenneth Hulse

University of Western Australia

H指数:46

被引数:7,180

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cannabinoid impacts on ethnic modulation of atrial septal defect prevalence USA

大麻素对美国房间隔缺损患病率中种族调节的影响

Journal of Perinatology

IF2.4

2026-05-010

PRE

Space-Time Analysis of Burgeoning US Atrial Septal Defect Rates Driven by Cannabis

美国房间隔缺损发病率增长的空间-时间分析：大麻驱动因素

Journal of Xenobiotics

IF4.4

2026-04-170

OAAI

Impact of Cannabis and Cannabis Legalization on US Atrial Septal Defect Rates

大麻及其合法化对美国房间隔缺损率的影响

Journal of Xenobiotics

IF4.4

2026-03-010

OAAI

Cannabis: multigenerational and food chain impacts

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

IF3.7

2025-04-010

PRE

Key insights into cannabis-cancer pathobiology and genotoxicity

ADDICTION BIOLOGY

IF2.6

2024-11-131

OA

Perturbation of 3D nuclear architecture, epigenomic aging and dysregulation, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 2-Metabolome, immunome, synaptome

FRONTIERS IN PSYCHIATRY

IF3.2

2023-10-030

OAAI

Cannabis Could Be the Missing Environmental Carcinogen Hiding in Plain View

GASTROENTEROLOGY

IF25.1

2023-10-013

PRE

Perturbation of 3D nuclear architecture, epigenomic dysregulation and aging, and cannabinoid synaptopathy reconfigures conceptualization of cannabinoid pathophysiology: part 1-aging and epigenomics

FRONTIERS IN PSYCHIATRY

IF3.2

2023-09-051

OAAI

Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study

JOURNAL OF XENOBIOTICS

IF4.4

2023-07-184

OAAI

Cannabis, Cannabidiol, Cannabinoids, and Multigenerational Policy

IF11.6

2023-04-016

OAAI

The role of flumazenil in generalised anxiety disorder: a pilot naturalistic open-label study with a focus on treatment resistance

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY

IF4

2023-03-151

OAAI

Geospatiotemporal and Causal Inferential Study of European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Orofacial Anomalies

JOURNAL OF XENOBIOTICS

IF4.4

2023-02-014

OAAI

Untitled Response

ARCHIVES OF PUBLIC HEALTH

IF3.2

2022-11-161

OAAI

Is the Precipitation of Anxiety Symptoms Associated with Bolus Doses of Flumazenil a Barrier to Its Use at Low Continuous Doses in Benzodiazepine Withdrawal?

JOURNAL OF CLINICAL MEDICINE

IF2.9

2022-10-081

OAAI

Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond

阿片成瘾的多性状全基因组关联研究: OPRM1及以上

SCIENTIFIC REPORTS

IF3.9

2022-10-0733

OAAI

Gaddis, Nathan; Mathur, Ravi; Marks, Jesse; Zhou, Linran; Quach, Bryan; Waldrop, Alex; Levran, Orna; Agrawal, Arpana; Randesi, Matthew; Adelson, Miriam; Jeffries, Paul W.; Martin, Nicholas G.; Degenhardt, Louisa; Montgomery, Grant W.; Wetherill, Leah; Lai, Dongbing; Bucholz, Kathleen; Foroud, Tatiana; Porjesz, Bernice; Runarsdottir, Valgerdur; Tyrfingsson, Thorarinn; Einarsson, Gudmundur; Gudbjartsson, Daniel F.; Webb, Bradley Todd; Crist, Richard C.; Kranzler, Henry R.; Sherva, Richard; Zhou, Hang; Hulse, Gary; Wildenauer, Dieter; Kelty, Erin; Attia, John; Holliday, Elizabeth G.; McEvoy, Mark; Scott, Rodney J.; Schwab, Sibylle G.; Maher, Brion S.; Gruza, Richard; Kreek, Mary Jeanne; Nelson, Elliot C.; Thorgeirsson, Thorgeir; Stefansson, Kari; Berrettini, Wade H.; Gelernter, Joel; Edenberg, Howard J.; Bierut, Laura; Hancock, Dana B.; Johnson, Eric Otto

Impact of converging sociocultural and substance-related trends on US autism rates: combined geospatiotemporal and causal inferential analysis

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

IF3.7

2022-07-026

OAAI

Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3-spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers

ARCHIVES OF PUBLIC HEALTH

IF3.2

2022-03-308

OAAI

Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2-categorical bivariate analysis and attributable fractions

ARCHIVES OF PUBLIC HEALTH

IF3.2

2022-03-3014

OAAI

Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1-continuous bivariate analysis

ARCHIVES OF PUBLIC HEALTH

IF3.2

2022-03-3015

OAAI

Quadruple convergence-rising cannabis prevalence, intensity, concentration and use disorder treatment

LANCET REGIONAL HEALTH-EUROPE

IF13

2021-11-0117

OA